Bozhidar Vladimirov Karamishev

Mr. Bozhidar Vladimirov Karamishev

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2024 in Journal of IMAB – Annual Proceeding (Scientific Papers)
Verified
Journal Article
Closed access
VSVictoria Spasova
Victoria Spasova
LKLiliya Koleva
Liliya Koleva
SPSofia Operative Gynecology Clinic Umbalsm N. I. Pirogov
Sofia Operative Gynecology Clinic Umbalsm N. I. Pirogov
SSSvetlana Yasenova Shumarova
Svetlana Yasenova Shumarova
DHDiana Hristova
Diana Hristova
VKVesela Karamisheva
Vesela Karamisheva
Purpose: This case study refers to a case of complete androgen insensitivity syndrome, which presented with amenorrhea back in the past. Case: After conformation of the diagnosis, parents decided not to reveal the condition’s specifics to the patient. At the age of 34 years, she attended our hospital with abdominal swelling, and the following CT scan showed an abdominal mass arising from the ovary of 13 cm x 14 cm size. A laparotomy was done, and a mixture of solid and cystic mass of 20 cm in diameter was found and removed with the ovary. Histopathology of the tumor showed features of testicular seminoma. Conclusion: The aim of this case report is to outline the difficulties in choosing whether and when to do the gonadectomy and whether and how to explain the condition to the patient.

14 July 2026
Verified
Book Chapter
Open access
PDF file
VKVesela Ivanova Karamisheva
Vesela Ivanova Karamisheva
MVMartin Vladimirov
Martin Vladimirov
DKDaria Zhivkova Koleva
Daria Zhivkova Koleva
AKAnatoli Kolev
Anatoli Kolev
BKBozhidar Vladimirov Karamishev
Bozhidar Vladimirov Karamishev
IVIavor K. Vladimirov
Iavor K. Vladimirov
Endometriosis (EM) is a chronic, estrogen-dependent, inflammatory disease characterized by the presence of endometrial-like tissue outside the uterus. It is estimated that EM occurs in approximately 10% of women of the reproductive age and is associated with severe morbidity in the form of chronic pelvic pain and subfertility. Diagnosis is challenging due to nonspecific symptoms, long diagnosis-to-treatment times (4–11 years), the inability of imaging techniques to accurately locate superficial lesions, and the lack of validated noninvasive biomarkers. The latest European Society of Human Reproduction and Embryology (ESHRE) and American College of Obstetricians and Gynecologists (ACOG) guidelines no longer consider laparoscopy as the reference standard test. Presently, the management of EM is focused on symptom control using hormones (such as combined oral contraceptives, progestins, and gonadotropin-releasing hormone analogs) and surgery in non-responders or for fertility preservation. However, EM is highly recurrent, with recurrence rates of up to 50% at five years after treatment, associated with numerous side effects and limited improvement in fertility preservation rates. Precision medicine for EM will require the identification of multiomic biomarkers of the disease to develop non-invasive approaches for the diagnosis and management of EM using artificial intelligence-based imaging technologies and novel immunomodulatory drugs.

19 January 2026 in Allergies
Verified
Journal Article
Open access
PDF file
Diana Mitkova HristovaDiana Mitkova Hristova
Diana Mitkova Hristova
MVMartin Vladimirov
Martin Vladimirov
BKBozhidar Vladimirov Karamishev
Bozhidar Vladimirov Karamishev
AKAnatoli Kolev
Anatoli Kolev
DKDaria Zhivkova Koleva
Daria Zhivkova Koleva
VKVesela Ivanova Karamisheva
Vesela Ivanova Karamisheva
Background: Presence of milk, fruits, eggs, fish, nuts and wheat antigens in the amniotic fluid is described in the literature. Studies show a contradictory relationship between maternal exposure to allergens and early sensitization of the fetus to allergens. Hemochorionic type of the human placenta allows for easier transfer of nutrients and antibodies from the mother’s blood to the fetal circulation through the direct contact of maternal blood with the fetal chorion. During the third trimester of pregnancy, immunoglobulin G (IgG) is actively transferred through the placenta into the fetal via neonatal FcRN receptor (FcRN). In addition, monomeric immunoglobulin E (IgE) cannot cross the placenta Aim: The objective of our study is to track intrauterine sensitization to essential food proteins at birth in umbilical cord blood in mothers with established peripheral blood eosinophilia and in their infants using allergen-specific IgE and IgG. Methods: An observational study was carried out in a cohort of 22 mothers with eosinophilia and their babies. Differences in expression between groups were assessed. Blood samples were collected to determine serum IgE and IgG specific to a set of inhalant and food allergens. Results: We did not find a significant correlation between specific IgE to cow’s milk (p = 0.857), egg white (p = 0.926) and egg yolk (p = 0.096) in umbilical cord blood and maternal blood samples taken immediately before birth. Spearman’s correlation of the specific IgE and IgG in umbilical cord blood showed no dependence between the two variables. In contrast, statistical analysis showed that maternal eosinophilia in peripheral blood could be a risk factor for the development of allergy in the offspring (χ2, p = 0.0347). However, given the small number of patients, this claim needs to be confirmed with further studies. Conclusions: Due to the functional immaturity of the developing immune system of the fetus, the generation and maintenance of an independent immune response to allergens are incomplete. Maternal IgG (specific) passes to the baby and high maternal IG to a specific allergen reduces babies IgE production. In addition, low maternal specific IgG may promote IgE production in the baby under the influence of microenvironmental factors (cytokine background). The main limitation of our study is the small number of patients. Further research is needed in this direction to clarify the mechanisms and risk factors for early sensitization in newborns.